Kidney Drug Metabolizing Activities in Streptozotocin Diabetic Rats

Publisher： Elsevier

ISSN： 0306-3623

Source： General Pharmacology, Vol.26, Iss.1, 1995-01, pp. : 137-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mangiferin mitigates diabetic cardiomyopathy in streptozotocin-diabetic rats

By Zheng Dezhi Zhong Guocheng Hu Yonghe

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 9, 2013-01 ,pp. : 759-763

NRC Research Press

Access to resources Recommend Favorite

The effect of agmatine on the vascular reactivity in streptozotocin-diabetic rats

By Ozyazgan S. Bicakci B. Ozaydin A. Denizbasi A. Unluer E.E. Akkan A.G.

Pharmacological Research, Vol. 48, Iss. 2, 2003-08 ,pp. : 133-138

Elsevier

Access to resources Recommend Favorite

Stereospecific disposition of fluvastatin in streptozotocin-induced diabetic rats

By Rocha Adriana Coelho Eduardo Barbosa Lanchote Vera Lucia

Canadian Journal of Physiology and Pharmacology, Vol. 80, Iss. 11, 2002-11 ,pp. : 1071-1075

NRC Research Press

Access to resources Recommend Favorite

Antidiabetic Effect of Spearmint in Streptozotocin-Induced Diabetic Rats

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 6, 2018-11 ,pp. : 581-589

Bentham Science Publishers

Access to resources Recommend Favorite

Abnormal incorporation and utilization of -tocopherol in erythrocyte membranes of streptozotocin-induced diabetic rats

By Shinozaki K. Takeda H. Inazu M. Matsumiya T. Takasaki M.

European Journal of Pharmacology, Vol. 456, Iss. 1, 2002-12 ,pp. : 133-139

Elsevier

Access to resources Recommend Favorite